Novo Nordisk Wegovy 1mg/0.5mL Pens Recall: Hair Found in Syringe
Novo Nordisk recalls Wegovy injections with hair in syringes. Affected units have lot numbers RZFYK06 or RZFYA53. Stop using immediately if you have these pens.
Stop using this now
Presence of Particulate Matter: Hair was found in a prefilled syringe
Contact the company
What happened, in plain English
Novo Nordisk is recalling Wegovy (semaglutide) injections that contain hair in the syringes. This could cause injury if the hair is injected into the body. People who have the specific lot numbers listed should stop using the product immediately. Read more at govinfonow.com/recall/31605-novo-nordisk-wegovy-1mg-0-5ml-pens-recall-hair-found.
Source Summary by GovInfoNow · govinfonow.com/recall/31605-novo-nordisk-wegovy-1mg-0-5ml-pens-recall-hair-found · Updated August 17, 2026 · FDA enforcement record: FDA #D-0245-2026
Cite this page
“Novo Nordisk Wegovy 1mg/0.5mL Pens Recall: Hair Found in Syringe.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31605-novo-nordisk-wegovy-1mg-0-5ml-pens-recall-hair-found. Based on FDA recall #D-0245-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0245-2026%22&limit=1).
Why it’s dangerous
Hair was found inside the prefilled syringe. If the hair is injected into the body, it could cause injury or infection. This is a serious hazard that requires immediate action.
Who’s affected
People who have Wegovy injections with lot numbers RZFYK06 or RZFYA53 are affected. Those who use the product for weight loss are most at risk.
How to tell if you have this one
Check the lot number on the Wegovy pen packaging. Affected units have lot numbers RZFYK06 or RZFYA53. The product was manufactured in Denmark and sold in the U.S. by Novo Nordisk Inc.
- Brand
Novo Nordisk- Category
Drug
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Ongoing- Distribution
Nationwide within the United States.
| Recall number | Product, codes & lots |
|---|---|
| D-0244-2026 | Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14; Lot #: RZFHD52, RZFHW93; Exp Date 10/31/2026 |
| D-0245-2026 | Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14; Lot #: RZFYK06, RZFYA53; Exp Date 3/31/2027 |
What to do — step by step
Stop Using Immediately
If you have Wegovy injections with lot numbers RZFYK06 or RZFYA53, stop using them right away.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide within the United States.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 19 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0245-2026 (December 19, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0245-2026 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.